4.5 Article

The trajectory of emotional and non-emotional cognitive function in newly diagnosed patients with bipolar disorder and their unaffected relatives: A 16-month follow-up study

Journal

EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume 67, Issue -, Pages 4-21

Publisher

ELSEVIER
DOI: 10.1016/j.euroneuro.2022.11.004

Keywords

Bipolar disorder; Unaffected relatives; Endophenotypes; Cognition; Emotional cognition; Longitudinal

Ask authors/readers for more resources

Cognitive impairments are present in remitted patients with bipolar disorder (BD) and their unaffected relatives (UR) compared to healthy controls (HC). However, the temporal course of cognition and whether it is marked by neuroprogressive changes are still unclear. In a prospective study, newly diagnosed patients with BD, UR, and HC were assessed using a comprehensive cognitive battery at baseline and 16-month follow-up. There was no evidence of trajectory differences in neurocognition and emotional cognition between BD patients, UR, and HC. BD patients showed stable impairments in global neurocognitive functioning over time, while UR had deficits in working memory and executive function. Poorer neurocognition and positive emotion regulation were associated with sub-syndromal symptoms and functional impairments.
Cognitive impairments are evident in remitted patients with bipolar disorder (BD) and their unaffected relatives (UR) compared to healthy controls (HC). However, the temporal course of cognition, and whether cognition is marked by neuroprogressive changes, remain unclear. In a large prospective study of newly diagnosed patients with BD, we assessed patients with BD ( n = 266), UR ( n = 105) and HC ( n = 190) using an extensive cognitive battery of non-emotional and emotional cognition at baseline and 16-months follow-up. Cognitive change across groups was examined with linear mixed-model analyses. Results showed no evidence of trajectory differences between patients with BD, UR, and HC in neurocognition and emotional cognition (ps >=.10). Patients with BD showed stable impairments in global neurocognitive functioning over time, as well as within the domains of 'working memory and executive function' and 'atten-tion and psychomotor speed', compared to HC. Patients who relapsed during the follow-up time were less successful at down-regulating emotions in positive social scenarios compared to HC. Unaffected relatives also displayed stable deficits in 'working memory and executive function' over time, with performance at intermediate levels between BD probands and HC. Finally, poorer neurocognition and positive emotion regulation were associated with more sub-syndromal symptoms and functional impairments. In conclusion, we found no evidence of a neuroprogressive origin of cognitive impairments in the newly diagnosed BD or in their UR. Patients' and UR's impairments in working memory and executive function may reflect a sta-ble cognitive trait-marker of familial risk. Difficulties with positive emotion regulation may be associated with illness progression in BD. (c) 2022 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available